Clinic News

Latest in Cardiology

HHS and FDA Release New Dietary Guidelines For Americans
The U.S. Department of Health and Human Services (HHS) and U.S. Department of Agriculture have released new Dietary Guidelines for Americans intended to guide federal nutrition policy for the next five years.
ACC Champions Legislative Priorities as Federal Funding Deadline Approaches
Members of Congress face a critical funding deadline as they return to the nation's capital at the start of the new year. Most of the federal government continues to operate under a short-term continuing resolution, with permanent funding for remaining appropriations bills or a new continuing resolution needed by Jan. 30 to avoid another shutdown.
Eagleâ€™s Eye View: Top 2025 ACC Content
In this episode, Dr. Eagle looks back at 2025 and explores some of the significant developments that show how the College is responding to changes in the way we evaluate, manage, and follow patients with various types of cardiovascular disorders.
SURPASS-CVOT: Is Tirzepatide Superior to Dulaglutide in Patients With T2D and ASCVD?
Tirzepatide was noninferior to dulaglutide among patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), with respect to the primary composite outcome of cardiovascular death, myocardial infarction (MI) or stroke...
Reducing Saturated Fat May Reduce Mortality, NFMI, Stroke in High-Risk Individuals
Among individuals with an elevated baseline cardiovascular risk, reducing the intake of saturated fatty acid (SFA) was associated with a lower risk of mortality, nonfatal myocardial infarction (NFMI) and stroke over five years, according to a systematic review published Dec. 16 in Annals of Internal Medicine.
The OPTION Trial: Percutaneous Left Atrial Appendage Occlusion Devices Rise as an Option Post Ablation
Catheter ablation has become an effective treatment strategy for patients with AF. In 2009, the ThermoCool AF (NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation) trial results showed that ablation to treat...
ACCEL Lite: Should There Be a Reappraisal of Surgical Threshold in Patients with AA Dilation?
In this interview, Glenn A. Hirsch MD, MHS, FACC and Milind Y. Desai, MD, MBA, FACC discuss â€œShould There Be a Reappraisal of Surgical Threshold in Patients with Ascending Aortic Dilation?".
Vericiguat in Heart Failure: Insights From the VICTOR Trial
Heart failure with reduced ejection fraction (HFrEF) remains a major public health burden, with persistent morbidity and mortality despite advances in contemporary guideline-directed medical therapy (GDMT).
Top ACC Content in 2025
The most popular ACC.org content items of 2025.
Significant Increases in Cardiopulmonary Illness Observed in the Wake of Historic California Wildfires
Los Angeles residents experienced significant increases in cardiopulmonary illness in the three months following the historic Eaton and Palisades wildfires that took place in January 2025, according to a study published in JACC.